Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2019 Oct 29;127(10):104002. doi: 10.1289/EHP5630

A Complex Relationship: Dietary Folate, Arsenic Metabolism, and Insulin Resistance in Mice

Silke Schmidt
PMCID: PMC6910776  PMID: 31660753

More than 144 million people worldwide are believed to drink water with inorganic arsenic (iAs) concentrations exceeding the World Health Organization guideline of 10 ppb.1 Consumption of drinking water with high levels of iAs—more than 100 ppb—has been associated with numerous adverse health outcomes in humans,2 including diabetes.3,4 A recent study5 published in Environmental Health Perspectives highlights the potential complexity of the iAs–diabetes relationship: Investigators reported that, under some conditions, dietary folate may modify both iAs metabolism and diabetes-related outcomes in mice.

Previous research and known biochemical processes motivated the animal experiments. Several studies have suggested that the way iAs is metabolized may influence the associated health outcomes, including type 2 diabetes.6,7,8 Some of the first evidence9 that folate supplementation may increase the efficiency of human iAs metabolism came from Bangladesh, where exposure to arsenic-contaminated drinking water is much more common than in the United States.

Photograph of women and children fetching water from a community well in Bangladesh

Exposure to potentially unsafe levels of iAs in drinking water is a problem for more than 144 million people worldwide. Bangladesh, India, the United States, and China are thought to have the largest populations of people exposed to concentrations above the World Health Organization guideline of 10 ppb.1 In parts of these and other countries, drinking-water levels of iAs far exceed that guideline. Image: © iStockphoto/Tarzan9280.

In humans and some animal species, iAs is metabolized in multiple methylation steps. The synthesis of an important methyl donor for these reactions requires folate, an essential micronutrient.10,11 The enzyme arsenic (+3 oxidation state) methyltransferase (AS3MT) catalyzes iAs methylation.12 “Since we wanted to test whether the influence of folate varies by iAs metabolic efficiency, we used wild-type strains and As3mt-knockout mice with a reduced ability to detoxify iAs,” says Madelyn Huang, a postdoctoral fellow at the National Toxicology Program and first author of the new study. “We also compared the same iAs exposure in male and female animals on a low-fat and high-fat diet.”

In their study design, the researchers varied four factors: genetic background (wild-type vs. knockout), folate intake (0.2 mg/kg vs. 10 mg/kg), iAs in drinking water (0 ppb vs. 100 ppb), and dietary fat content. To minimize background dietary iAs, the mice received a purified low-fat diet. After 24 weeks, all the animals were switched to a high-fat diet to see if the added metabolic stress of an obesogenic regimen would alter the separate and combined effects of iAs and folate.

Consistent with a previous study by members of this group,13 As3mt-knockout mice were more likely than wild-type mice to become obese and develop insulin resistance, regardless of iAs exposure. The study also generated two novel findings: “Only obese and folate-deficient wild-type mice, male and female, that were exposed to arsenic developed insulin resistance,” says study leader Miroslav Stýblo, a professor of nutrition at the University of North Carolina at Chapel Hill. “But high folate intake, which rescued this phenotype [i.e., reversed insulin resistance] in both sexes, modified iAs metabolism only in female mice.”

These sex-specific effects are worth pursuing, according to Brandon Pierce, an associate professor of public health sciences at the University of Chicago who was not involved in the study. “In prior studies of humans, we have observed sex differences related to arsenic metabolism and arsenic-related disease risks, but the reasons for these differences are not well understood,” he says.

Pierce and colleagues are conducting several human studies in Bangladesh. Although these studies include only a small number of obese individuals, they are yielding evidence that diet may modify the risk of arsenic-induced skin lesions.14 This finding, Pierce says, is consistent with the new study’s evidence for a potential interaction between iAs exposure and dietary factors.

Ana Navas-Acien, a professor of environmental health sciences at Columbia University and also not involved in the study, notes similarities with other studies. “In our human population,15 the combination of arsenic exposure, low folate intake, and a fatty diet increased the risk of diabetes,” she says. “And I think one of [the new] study’s most important findings is that the As3mt-knockout mice were more obese under almost all conditions. This suggests that human AS3MT may play an important role in fat accumulation.”

Although it is possible that folate influences insulin resistance via iAs metabolism, Stýblo notes that other mechanisms cannot be ruled out. “Folate may have a larger systemic effect, perhaps involving changes in DNA methylation patterns for genes involved in glucose metabolism,” he says. “More work is needed to understand the role of both iAs and folate in the development of diabetes and other metabolic diseases.”

Biography

Silke Schmidt, PhD, writes about science, health, and the environment from Madison, Wisconsin.

References

  • 1.Ravenscroft P, Brammer H, Richards K. 2009. Synthesis, Conclusions and Recommendations In: Arsenic Pollution: A Global Synthesis. West Sussex, UK: John Wiley & Sons, pp. 492–527, 10.1002/9781444308785. [DOI] [Google Scholar]
  • 2.Kuo CC, Moon KA, Wang SL, Silbergeld E, Navas-Acien A. 2017. The association of arsenic metabolism with cancer, cardiovascular disease, and diabetes: a systematic review of the epidemiological evidence. Environ Health Perspect 125(8):087001, PMID: 28796632, 10.1289/EHP577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sung TC, Huang JW, Guo HR. 2015. Association between arsenic exposure and diabetes: a meta-analysis. Biomed Res Int 2015:368087, PMID: 26000288, 10.1155/2015/368087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, et al. . 2012. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 120(12):1658–1670, PMID: 22889723, 10.1289/ehp.1104579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Huang MC, Douillet C, Dover EN, Zhang C, Beck R, Tejan-Sie A, et al. . 2018. Metabolic phenotype of wild-type and As3mt-knockout C57BL/6J mice exposed to inorganic arsenic: the role of dietary fat and folate intake. Environ Health Perspect 126(12):127003, PMID: 30675811, 10.1289/EHP3951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Antonelli R, Shao K, Thomas DJ, Sams R, Cowden J. 2014. AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility. Environ Res 132:156–167, PMID: 24792412, 10.1016/j.envres.2014.03.012. [DOI] [PubMed] [Google Scholar]
  • 7.Hall MN, Gamble MV. 2012. Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity. J Toxicol 2012:595307, PMID: 22523489, 10.1155/2012/595307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Castriota F, Acevedo J, Ferreccio C, Smith AH, Liaw J, Smith MT, et al. . 2018. Obesity and increased susceptibility to arsenic-related type 2 diabetes in Northern Chile. Environ Res 167:248–254, PMID: 30059859, 10.1016/j.envres.2018.07.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. . 2006. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid–supplementation trial in Bangladesh. Am J Clin Nutr 84(5):1093–1101, PMID: 17093162, 10.1093/ajcn/84.5.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Selhub J. 1999. Homocysteine metabolism. Annu Rev Nutr 19(1):217–246, PMID: 10448523, 10.1146/annurev.nutr.19.1.217. [DOI] [PubMed] [Google Scholar]
  • 11.Thomas DJ, Stýblo M, Lin S. 2001. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176(2):127–144, PMID: 11601889, 10.1006/taap.2001.9258. [DOI] [PubMed] [Google Scholar]
  • 12.Thomas DJ, Li J, Waters SB, Xing W, Adair BM, Drobna Z, et al. . 2007. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med (Maywood) 232(1):3–13, PMID: 17202581, 10.1093/toxsci/kfp250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Douillet C, Huang MC, Saunders RJ, Dover EN, Zhang C, Stýblo M. 2017. Knockout of arsenic (+3 oxidation state) methyltransferase is associated with adverse metabolic phenotype in mice: the role of sex and arsenic exposure. Arch Toxicol 7:2617–2627, PMID: 27847981, 10.1007/s00204-016-1890-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pierce BL, Argos M, Chen Y, Melkonian S, Parvez F, Islam T, et al. . 2011. Arsenic exposure, dietary patterns, and skin lesion risk in Bangladesh: a prospective study. Am J Epidemiol 173(3):345–354, PMID: 21178101, 10.1093/aje/kwq366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Grau-Perez M, Kuo C-C, Gribble MO, Balakrishnan P, Jones Spratlen M, Vaidya D, et al. . 2017. Association of low-moderate arsenic exposure and arsenic metabolism with incident diabetes and insulin resistance in the Strong Heart Family Study. Environ Health Perspect 125(12):127004, PMID: 29373862, 10.1289/EHP2566. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES